Catalyst Wire Dossier Catalyst Wire Dossier

Indigotindisulfonate Sodium Injection, USP

indigotindisulfonate sodium · Provepharm Life Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Indigotindisulfonate Sodium Injection, USP, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients [Phase 3]

See pricing